Clinical Trials Logo

Clinical Trial Summary

The study investigates two groups of participants of the SÄPT therapist's training starting in October 2022. The overall objective is to investigate the risks and benefits of personal experience (PE) with substance-induced altered states of consciousness for physicians or psychotherapists in the context of a training course for substance-assisted therapy. Specifically, the study aims to assess changes in therapeutic attitude and other factors important in interactions between patients and therapists (such as empathy and cognitive flexibility).


Clinical Trial Description

n/a


Study Design


NCT number NCT05570708
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Enrolling by invitation
Phase N/A
Start date October 25, 2022
Completion date June 1, 2029